Aptevo Therapeutics Inc

NASDAQ:APVO   3:59:41 PM EDT
43.76
-0.63 (-1.42%)
Earnings Announcements

Aptevo Therapeutics Reports Qtrly Loss Per Share Of $2.10

Published: 11/10/2020 23:35 GMT
Aptevo Therapeutics Inc (APVO) - Aptevo Therapeutics Inc - Qtrly Loss per Share $2.10.
Aptevo Therapeutics Inc - Funding Extends Cash Runway Into 2022.
Revenue is expected to be $1.73 Million
Adjusted EPS is expected to be -$1.51

Next Quarter Revenue Guidance is expected to be $1.99 Million
Next Quarter EPS Guidance is expected to be -$1.33

More details on our Analysts Page.